glycyrrhizic acid has been researched along with Acute Confusional Senile Dementia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, N; Bittar, A; Gaikwad, S; Garcia, S; Kayed, R; McAllen, S; Montalbano, M; Puangmalai, N; Sengupta, U; Sonawane, M | 1 |
| Chen, X; Hua, HP; Kong, ZH; Liang, L; Liu, LJ | 1 |
| Abdel Bar, FM; Badria, FA; El-Senduny, FF; Elimam, DM; Mira, AS | 1 |
| Liew, KB; Peh, KK; Tan, YT | 1 |
| Fu, Y; Link, P; Wetterauer, B; Wink, M | 1 |
| Chen, C; Chen, Y; Guan, D; Jin, J; Wang, X; Wang, Z; Xu, Y; Ye, D; Ye, L; Zhao, H; Zhu, X | 1 |
1 trial(s) available for glycyrrhizic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Topics: Adult; Alzheimer Disease; Donepezil; Double-Blind Method; Drug Compounding; Drug Costs; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Storage; Excipients; Glycyrrhizic Acid; Hardness; Humans; Indans; Mouth Mucosa; Nootropic Agents; Patient Preference; Piperidines; Salvia; Sweetening Agents; Tablets; Taste; Taste Perception | 2015 |
5 other study(ies) available for glycyrrhizic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia.
Topics: Alzheimer Disease; Animals; Astrocytes; Brain; Cell Nucleus; Cells, Cultured; Cellular Senescence; Cognition Disorders; Frontotemporal Dementia; Glycyrrhizic Acid; HMGB1 Protein; Humans; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Protein Transport; Pyruvates; tau Proteins | 2021 |
The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer's-Related Pathology via HMGB1 Inhibition.
Topics: Administration, Oral; Alzheimer Disease; Animals; Anti-Inflammatory Agents; Brain; Cognitive Dysfunction; Cytokines; Disks Large Homolog 4 Protein; Glycyrrhizic Acid; HMGB1 Protein; Male; Maze Learning; Mice; Mice, Inbred C57BL; NF-kappa B; Splenectomy; tau Proteins; Toll-Like Receptor 4 | 2017 |
Derivatization, molecular docking and
Topics: Alzheimer Disease; Antioxidants; Cell Survival; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Fibroblasts; Glycyrrhizic Acid; Humans; Molecular Docking Simulation; Molecular Structure; Wound Healing | 2019 |
Extracts of Glycyrrhiza uralensis and isoliquiritigenin counteract amyloid-β toxicity in Caenorhabditis elegans.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Chalcones; Flavanones; Glycyrrhetinic Acid; Glycyrrhiza uralensis; Glycyrrhizic Acid; Humans; Phytotherapy; Plant Extracts | 2015 |
Diammonium glycyrrhizinate upregulates PGC-1α and protects against Aβ1-42-induced neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Caspase 3; Caspase 9; Cells, Cultured; Disease Models, Animal; Glycyrrhizic Acid; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neurons; Neuroprotective Agents; Peptide Fragments; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Trans-Activators; Transcription Factors; Up-Regulation | 2012 |